Literature DB >> 2777652

Sebaceous carcinoma of the ocular adnexa: radiotherapeutic management.

F S Pardo1, C C Wang, D Albert, M A Stracher.   

Abstract

A total of 30 patients with histologically confirmed sebaceous carcinoma of the ocular adnexa were evaluated at our institution from 1974-1986. There were 18 women and 12 men in the series with a median age of 61 years. Ten cases received radiotherapy with curative intent. Four patients were treated definitively with doses ranging from 45-63.0 Gy over 4-7 weeks. Six patients received post-operative radiotherapy to the parotid bed and ipsilateral cervical lymph node chain for parotid metastases developing within 36 months of initial surgical treatment. Patients with lower lid lesions and significant pagetoid histologic components were more likely to develop parotid lymph node metastases. Local control at the primary site after radiation and/or surgery was 90% with follow-up ranging from 2-10 years. Overall disease specific actuarial survival at 5 years was 96%. Radiation therapy is an effective treatment modality in adnexal sebaceous carcinoma. With employment of careful technique and state-of-the-art technology, long term local control and survival with satisfactory cosmetic and functional results can be anticipated.

Entities:  

Mesh:

Year:  1989        PMID: 2777652     DOI: 10.1016/0360-3016(89)90117-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Sebaceous carcinoma of the eyelid: a clinicopathological study.

Authors:  M Zürcher; C R Hintschich; A Garner; C Bunce; J R Collin
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  Neoadjuvant Systemic Chemotherapy in Sebaceous Gland Carcinoma of the Eyelid: A Retrospective Study.

Authors:  Saurav Verma; Nipun Kumar; Rachna Meel; Seema Sen; Seema Kashyap; Sanjay Sharma; Neelam Pushker; Deepam Pushpam; Sameer Bakhshi
Journal:  Ocul Oncol Pathol       Date:  2021-05-05

3.  Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function.

Authors:  M Hata; I Koike; J Maegawa; A Kaneko; K Odagiri; T Kasuya; Y Minagawa; H Kaizu; Y Mukai; T Inoue
Journal:  Strahlenther Onkol       Date:  2012-10-28       Impact factor: 3.621

4.  Locally aggressive and multicentric recurrent extraocular sebaceous carcinoma: case report and literature review.

Authors:  Advaith Bongu; Edward S Lee; Stephen R Peters; Ravi J Chokshi
Journal:  Eplasty       Date:  2013-08-21

5.  Radiotherapy for localized sebaceous carcinoma of the eyelid: a retrospective analysis of 83 patients.

Authors:  Yoshiaki Takagawa; Wakana Tamaki; Shigenobu Suzuki; Koji Inaba; Naoya Murakami; Kana Takahashi; Hiroshi Igaki; Yuko Nakayama; Naoyuki Shigematsu; Jun Itami
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

6.  Long-Term Remission of an Aggressive Sebaceous Carcinoma following Chemotherapy.

Authors:  Angela Orcurto; Béatrice E Gay; Wendy Jeanneret Sozzi; Michel Gilliet; Serge Leyvraz
Journal:  Case Rep Dermatol       Date:  2014-03-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.